ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,483Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 93

$592K Total Retail Price of All Prescriptions

Rank: 8 out of 93

395 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 503 449 1 3
METFORMIN HCL 419 326 2 7
PRAVASTATIN SODIUM 358 322 3 20
LEVOTHYROXINE SODIUM 343 311 4 5
FUROSEMIDE 329 292 5 4
AMLODIPINE BESYLATE 296 264 6 6
OMEPRAZOLE 273 242 7 8
CRESTOR 223 170 8 31
POTASSIUM CHLORIDE 204 183 9 13
TRAMADOL HCL 179 144 10 15
HYDROCODONE-ACETAMINOPHEN 168 113 S3 11 9
MELOXICAM 168 136 11 42
WARFARIN SODIUM 162 140 13 12
HYDROCHLOROTHIAZIDE 155 153 14 10
GABAPENTIN 146 117 15 17
ALENDRONATE SODIUM 130 116 16 39
TAMSULOSIN HCL 127 104 17 24
METOPROLOL TARTRATE 125 93 18 11
SIMVASTATIN 116 116 19 2
LOSARTAN POTASSIUM 110 110 20 26
METOPROLOL SUCCINATE 98 84 21 14
BYSTOLIC 97 72 22 116
SYNTHROID 97 91 22 77
GLIPIZIDE 96 81 24 41
LANTUS 94 87 25 68
ALLOPURINOL 93 85 26 29
ATENOLOL 93 90 26 16
FENOFIBRATE 93 63 26 74
CARVEDILOL 92 90 29 23
DONEPEZIL HCL 88 88 30 25
DIGOXIN 87 87 31 48
FLUOXETINE HCL 83 80 32 82
ZOLPIDEM TARTRATE 81 60 33 40
SERTRALINE HCL 81 67 33 43
PANTOPRAZOLE SODIUM 78 58 35 36
PLAVIX 78 69 35 44
PREDNISONE 74 57 37 49
CIPROFLOXACIN HCL 73 63 38 106
ADVAIR DISKUS 70 50 39 59
TRICOR 69 43 40 143
AZITHROMYCIN 68 62 41 51
CLOPIDOGREL 67 51 42 27
LYRICA 64 40 43 141
SPIRIVA 63 42 44 69
NIASPAN 62 48 45 89
LEVOFLOXACIN 62 53 45 103
EVISTA 60 60 47 172
CYMBALTA 55 37 48 84
INSULIN SYRINGE 55 42 48 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 48 28
DILTIAZEM 24HR ER 53 53 51 105
TRIAMCINOLONE ACETONIDE 52 46 52 140
ATORVASTATIN CALCIUM 52 52 52 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.